Old Web
English
Sign In
Acemap
>
Paper
>
Eribulin Mesylate improving survival outcomes of metastatic breast cancer
Eribulin Mesylate improving survival outcomes of metastatic breast cancer
2017
Maki Nakai
M. Suzuki
Tomoko Kurita
Keiko Yanagihara
Hiroyuki Takei
Keywords:
Eribulin Mesylate
Medicine
Oncology
Metastatic breast cancer
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]